The new Rochester processing centre in the US will allow users to access the supercomputing system over a secure virtual private network, and pay only for the amount of processing capacity reserved.
IBM says that while some of the most ambitious supercomputing work will still take place in government labs, commercial markets such as drug discovery, product design, simulation and animation, financial and weather modelling will increasingly demand IBM’s new facilities.
Blue Gene is targeted at companies which cannot afford to buy a supercomputer for their own needs, as well as at those who require the scalable solution that Blue Gene provides.
The IBM eServer-based Blue Gene solution provides a peak performance of 5.7 teraflops via a single full rack system, with a footprint of less than one square metre.
The on-demand computer processing model has also recently been promoted by Sun Microsystems, which launched its own product last month.